Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Iecure Inc.
Sponsor

Iecure Inc.

United States 1777 Sentry Parkway West Suite 200 Building 14, 19422-2211, United States

About the sponsor

Clinical research is centered on ornithine transcarbamylase deficiency (OTC deficiency), with attention to the metabolic consequences of impaired ammonia detoxification in early-onset disease.

  • Neonatal-onset OTC deficiency
  • Inherited metabolic disease
  • Ammonia metabolism

Interest is focused on pediatric patients with severe urea cycle dysfunction, particularly in the setting of early-life presentation.

About Specializations

Iecure Inc. runs clinical trials in conditions such as Ornithine transcarbamoylase deficiency, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Ornithine transcarbamoylase deficiency

Recruiting
InvestigationalNo placebo
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Adeno-Associated Virus Serotype Rh79 Containing The Human Otc Gene
  • Sponsor:Iecure Inc.

Ornithine transcarbamoylase deficiency

Not recruiting
InvestigationalNo placebo
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Adeno-Associated Virus Serotype Rh79 Containing The Human Otc Gene
  • Sponsor:Iecure Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.